Harry Kleanthous
Corporate Officer/Principal chez SK BIOSCIENCE CO.,LTD.
Postes actifs de Harry Kleanthous
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| SK BIOSCIENCE CO.,LTD. | Corporate Officer/Principal | 21/10/2022 | - |
Acambis Plc
 Acambis Plc BiotechnologyHealth Technology Acambis Plc develops biopharmaceutical products and vaccines. It offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets and travelers. Its products in pipeline include ChimeriVax-JE, ChimeriVax-West Nile, and ChimeriVax-Dengue. The company was founded in 1992 and is headquartered in Cambridge, UK. | Corporate Officer/Principal | - | - |
Historique de carrière de Harry Kleanthous
Formation de Harry Kleanthous
| University of London | Doctorate Degree |
Statistiques
Internationale
| Royaume-Uni | 3 |
| Corée du Sud | 2 |
Opérationnelle
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SK BIOSCIENCE CO.,LTD. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Acambis Plc
Acambis Plc BiotechnologyHealth Technology Acambis Plc develops biopharmaceutical products and vaccines. It offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets and travelers. Its products in pipeline include ChimeriVax-JE, ChimeriVax-West Nile, and ChimeriVax-Dengue. The company was founded in 1992 and is headquartered in Cambridge, UK. | Health Technology |
- Bourse
- Insiders
- Harry Kleanthous
- Expérience
